<DOC>
	<DOCNO>NCT00643396</DOCNO>
	<brief_summary>The majority patient small cell lung cancer incurable extensive stage disease . The usual initial treatment condition chemotherapy produce responses 50-80 % patient . Despite , cancer usually return . Once common body region re-grows chest , cause symptom shortness breath , cough , difficulty swallowing , pain bleeding . These symptom worsen patient 's quality life situation life-threatening . In study , propose give patient extensive stage small cell lung cancer respond chemotherapy radiotherapy treatment chest . By give type radiation cancer chance re-grow , hope control disease within chest prevent future symptom may cause cancer re-grow chest . Patients treat protocol check regularly disease control , quality life radiation side effect , .</brief_summary>
	<brief_title>Phase II Trial Consolidative Thoracic Radiotherapy Extensive Stage Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>Histologic cytologic confirmation small cell lung cancer extensive stage disease adequate pulmonary function test ( FEV1 &gt; 1.0 , DLCO &gt; 50 % ) patient childbearing potential must practice adequate contraception age ≧ 18 year Karnofsky performance status ≧ 70 document objective response initial chemotherapy sign studyspecific inform consent form complete subtotal tumor resection nonsmall cell histology prior concurrent malignancy except nonmelanoma skin cancer unless diseasefree least 5 year prior chest neck RT inadequate pulmonary function test ( FEV1 &lt; 1.0 OR DLCO &lt; 50 % ) pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>small cell lung cancer</keyword>
	<keyword>radiotherapy</keyword>
</DOC>